Researcher discovers paper published by co-author in another journal

In February 2016, Albert Jambon received some puzzling news.

Several colleagues had alerted him to a paper, published online in late December 2015 in the Journal of African Earth Sciences (JAES), reporting the discovery of a rare mineral, which Jambon had been analyzing.

When Jambon read the paper, he realized it was a modified version of a paper he had been working on for almost eight years. Impatient, one of his co-authors, Ahmad Bilal, had published his own version of the manuscript and listed himself as the sole author.

Jambon, a professor at Pierre and Marie Curie University, believes that Bilal’s paper plagiarized his manuscript, but Bilal disputes this allegation. Bilal–who works at Damascus University in Syria–says he couldn’t wait any longer to publish the manuscript, so wrote “a completely new version.” Since the authors couldn’t resolve the authorship dispute, in August 2016, the journal issued a “temporary” expression of concern, alerting readers to the authorship concerns. Now, a year and a half later, a spokesperson for the publisher says it’s going to be retracted.

Eight years is a long time to work on a paper.

Continue reading Researcher discovers paper published by co-author in another journal

Authorship for sale: Some journals willing to add authors to papers they didn’t write

Got $300? Then you can be added as an author to a paper — even if you had no role in the research.

That’s right — some journals are willing to add authors to papers they didn’t write, often for a fee. This realization comes from one of the many sting experiments we’ve witnessed over the years, designed to expose the perils of the publishing industry, in which some journals will claim to peer review and publish any manuscript for a fee — no matter how nonsensical the content. Pravin Bolshete, a medical writer and researcher from India, wanted to explore a different side of predatory publishing — would journals agree to add a fictional author to a manuscript he/she didn’t write?

Presenting his findings at the Eighth Peer Review Congress this week in Chicago, Bolshete reported that, after sending hundreds of emails to publishers considered predatory according to the now-defunct (and controversial) list compiled by librarian Jeffrey Beall, 16% agreed to add an author to a paper.

Bolshete told us:

Continue reading Authorship for sale: Some journals willing to add authors to papers they didn’t write

Bone researcher is up to 17 retractions

A bone researcher has lost three more papers for scientific misconduct.

The new retractions bring Yoshihiro Sato’s total to 17 and put him on our Leaderboard.

According to the retraction notices, Sato asked the Journal of Neurology, Neurosurgery, and Psychiatry to retract three of his papers “due to scientific misconduct.” In the letter, Sato—who is corresponding author on all three papers—explained he included co-authors without their consent and that none of the other authors listed worked on the study or article.

In May, the editors issued expressions of concern while they investigated (1, 2, 3), and last month, the journal retracted the three articles.

Here’s the retraction notice for “Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson’s disease:” Continue reading Bone researcher is up to 17 retractions

Former MD Anderson researcher objects to retraction of his paper

A cell biology journal has retracted a 2016 paper after an investigation revealed that the corresponding author failed to include two co-authors and acknowledge the funding source.

According to the retraction notice, the Journal of Cellular Physiology retracted the paper after the University of Texas, MD Anderson Cancer Center found that last author Jin Wang had omitted two researchers from the list of authors, and had also failed to acknowledge funding from the U.S. National Institutes of Health (NIH).

But Wang tells a different story. Continue reading Former MD Anderson researcher objects to retraction of his paper

Hey, that’s my case study: Another retraction after doctors claim rights to case write-up

A group of researchers have retracted their 2016 case report about a rare dermatologic disorder in the wake of disputes about authorship and institutional approval.

The paper describes a young boy with Job’s Syndrome, in which patients experience painful, itchy and frequently disfiguring skin lesions, along with a constellation of other possible symptoms. The condition is extremely rare, occurring in less than one in 1 million births.

This isn’t the first time a journal has retracted a case study after another group of authors claimed ownership of the case. Earlier this year, we covered a retraction from a neuro-ophthalmology journal after the doctors who treated a patient suffering from a gruesome eye trauma took issue with the fact that radiologists had already published their diagnostic images as a case study.

According to the notice for this latest retraction:

Continue reading Hey, that’s my case study: Another retraction after doctors claim rights to case write-up

After 35 years, philosophy journal corrects article…by a cat

A cat philosopher, via Pixabay

In 1982, Bruce Le Catt wrote a response to a paper in the Australasian Journal of Philosophy critiquing an earlier article about prosthetic vision.

But Le Catt was no ordinary author. No, he was a cat, the beloved pet of David Lewis, a world-class philosopher who just happened to be the author of the article about which Bruce Le Catt was commenting.

Lewis’ inside joke wasn’t lost on those who knew him, and the benign deception seems to have been common knowledge in the field since the Le Catt paper appeared in 1982 (which also happens to be the year Cats began its run on Broadway). The paper has been cited four times since it was published, according to Clarivate Analytics. But 25 years later, the journal has finally decided to put an end to the gag.

The joyless notice states plainly: Continue reading After 35 years, philosophy journal corrects article…by a cat

Fake peer review, forged authors, fake funding: Everything’s wrong with brain cancer paper

The paper had everything: Fake peer review, forged authors, even a fake funder.

In other words, it had nothing.

A 2015 paper is the latest retraction stemming from an investigation into fake peer review by Springer, which has now netted more than a hundred papers.

According to a spokesperson at Springer: Continue reading Fake peer review, forged authors, fake funding: Everything’s wrong with brain cancer paper

Unintended consequences: How authorship guidelines destroyed a relationship

It started as a simple email exchange over authorship. But it angered one researcher so much that it ended a 20-year collaboration.

In January 2017, a chemist based in Mexico had finished writing a paper describing the structure of a molecule. Sylvain Bernès, at the Instituto de Física Luis Rivera Terrazas, asked his co-author—the head of the lab where the molecule had been synthesized 10 years ago—to review the draft and include any co-authors involved in the initial work.

The researcher added three co-authors to the paper. Bernès became concerned. He wanted to follow the International Committee of Medical Journal Editors (ICMJE) authorship recommendations as strictly as possible. As far as Bernès could tell, none of the new authors had actually contributed to the work, potentially violating the recommendation about authorship contributions. Continue reading Unintended consequences: How authorship guidelines destroyed a relationship

Journal retracts two papers by authors who lifted others’ data

A journal has retracted two 2014 papers after the editors discovered the authors used data from other research groups without permission.

The papers, both published in the same issue of Cell Biochemistry and Biophysics and retracted in May, suffered from similar issues—the authors published data that was not theirs. The authors are all based at different institutions in China; as far as we can tell, the papers do not have any authors in common.

When we asked the publisher whether a third party, such as a paper mill, may have been involved, a spokesperson for Springer told us: Continue reading Journal retracts two papers by authors who lifted others’ data

Springer purge of fake reviews takes down 10+ more neuroscience papers

Back in April, Springer retracted a record number 107 papers from Tumor Biology after uncovering evidence they were subject to fake peer reviews. But it appears that the Tumor Biology sweep was only part of the story.

During the Tumor Biology investigation, Springer found evidence that the “peer review process was compromised” in a dozen papers on brain cancer published in another journal. The 12 Molecular Neurobiology retractions have trickled in over the past year or so, published before and after the Tumor Biology sweep.

A spokesperson at Springer confirmed that the 12 retracted papers in Molecular Neurobiology were related to the Tumor Biology retractions for fake peer review: Continue reading Springer purge of fake reviews takes down 10+ more neuroscience papers